Nobel Biocare Receives FDA Clearance for the N1 Implant System

Article

This implant system from Nobel Biocare that combines biological design and treatment protocols has received FDA clearance.

Nobel Biocare Receives FDA Clearance for the N1 Implant System

Nobel Biocare Receives FDA Clearance for the N1 Implant System

The United States Food and Drug Administration (FDA) has cleared the Nobel Biocare N1 implant system. The N1 is said to be a complete system for implants, including instruments, prosthetics, and surgical protocols. These instruments include the Osseoshaper, which shapes the osteotomy without irrigation and is designed to increase patient comfort and preserve bone.

This N1 implant system also includes Xeal and TiUltra treatments. These are abutments and implants respectively designed to make for easier tissue integration. These will be integrated into the DTX Studio for a fully digital workflow. With federal 510(k) clearance, access to this implant system expands, reaching more patients, according to Patrik Eriksson, President Nobel Biocare.

"Drilling protocols have hardly changed over the past 50 years. However, the OsseoShaper™ provides a completely new approach designed for patient comfort, streamlined workflow, and improved predictability; while at the same time, respects biology to achieve fast osseointegration,” Eriksson said in a press release from the company. “We are excited to partner with clinicians to bring the N1 system to US-based patients."

With FDA clearance, Nobel Biocare hopes to bring the N1 Implant System to North American markets in the near future.

Recent Videos
CDA 2024 Video Interview with Kuraray Noritake's Dinesh Weerasinghe and Richard Young, DDS
The Uptime Health Story: An Interview with Uptime Health CEO and Co-Founder Jinesh Patel
2024 Dental Products Report Spring Selection Bracket Reveal Video
2024 Chicago Dental Society Midwinter Meeting – Interview with Peter Maroon, business development and sales lead at Spectrum Solutions® on the new salivary diagnostic test, SimplyPERIO.
CDS 2024: Ivoclar's e.max ZirCAD Prime Blocks with Shashi Singhal, BDS, MS
CDS 2024: What's New at TAG University? with Andrew De la Rosa, DMD
CDS 2024: Breaking Down Barriers to Care with Eric Kukucka, DD
Product Bites – March 8, 2024 Part 2
Product Bites – March 8, 2024 Part 1
© 2024 MJH Life Sciences

All rights reserved.